The IACH meeting is sponsored by the pharmaceutical industry via sponsorships and exhibition packages. Companies have had no further input into the arrangements, agenda or scientific content of the meeting.
IACH Annual Meeting
Menarini Stemline
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. For more information, visit www.msd.com and connect with us on X, LinkedIn and YouTube.
Merck Sharp & Dohme LLC,
Rahway, NJ, USA
Merck Sharp & Dohme LLC
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. For more information, visit www.msd.com and connect with us on X, LinkedIn and YouTube.
Merck Sharp & Dohme LLC,
Rahway, NJ, USA
Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Contact: https://www.sanofi.com/en/contact
Website: https://www.sanofi.com/
Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people.
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285 USA
BeOne
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.
To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook and Instagram.
Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Learn more at https://innovativemedicine.jnj.com/emea/.
medac
The medac Group is committed to improving patients’ quality of life worldwide by providing access to the best possible medical therapies. As a globally operating pharmaceutical company headquartered in Germany, we are active in more than 90 countries and employ over 2,000 people worldwide. With production sites in Europe and a focus on rheumatology, urology, hematology, and oncology, medac develops and markets high-quality originator products, generics, and biosimilars.
medac GmbH | Theaterstraße 6 | 22880 Wedel | Germany
medac-group.com | LinkedIn
Takeda
Takeda Oncology is committed to advancing care for people living with cancer. Building on nearly three decades of oncology leadership, we focus on developing and delivering innovative therapies that address unmet patient needs. Our research and development efforts span thoracic, gastrointestinal, and hematologic cancers, with expertise in antibody-drug conjugates (ADCs), complex biologics, and small molecules. Through scientific innovation and collaboration with partners across the healthcare community, we strive to expand treatment options and improve outcomes for patients worldwide. Together, we are working to bring life-changing medicines to more people affected by cancer.
Daiichi Sankyo
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular and other diseases with high unmet medical need.
https://www.daiichi-sankyo.eu/
Daiichi Sankyo
Zielstattstr. 48 81379
Munich Germany
Incyte
Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
Since 2002 Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders.
Incyte’s unique expertise in medicinal chemistry and biology have enabled us to create a diversified pipeline of clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing portfolio of medicines across Oncology and Inflammation & Autoimmunity.
Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia. For more information, visit Incyte.com and follow @Incyte.
Sumitomo Pharma
Driven by a pursuit of innovation on behalf of the patients we serve, Sumitomo Pharma America, Inc. (SMPA) delivers needed products and accelerates drug development in key areas of unique and unmet medical need for people worldwide. Across multiple therapeutic areas and clinical research programs, including oncology, women’s health, urology, rare disease, CNS and cell & gene therapies, we operate with scientific rigor, compassion and determination to bring needed therapies to patients sooner, and to deliver better experiences for patients and caregivers on the things that matter most to them.